Indeed, in our cohort of COVID-19 patients, SARS-CoV-2 infection induced an increase in the expression of PD-1 and TIM-3 in both subsets of γδ T lymphocytes, as previously reported [49]. This evidence concerns the gene HAVCR2 and COVID-19.